Antitrust Antitrust

Roche's Covid-19 testing formula draws Dutch antitrust scrutiny

By Michael Acton
  • 27 Mar 2020 12:38
  • 27 Mar 2020 13:02

Swiss healthcare multinational Roche has drawn scrutiny from the Dutch Competition Authority over a formula used for its Covid-19 tests, MLex has learned.

The company has now shared it with the Dutch government in the wake of reports that laboratories were unable to make their own versions of a solution used in

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Discover MLex

Stay on top of global regulatory developments


Latest News